News Articles Tagged: Lysosomal Storage Disorders

N-Butyldeoxynojirimycin (OGT 918) in Clinical Use: From Research to Therapeutic Application

Explore the journey of N-Butyldeoxynojirimycin (OGT 918, CAS 72599-27-0) from scientific research to its clinical approval for lysosomal storage disorders. Learn about its therapeutic applications and the role of reliable suppliers.

Understanding Miglustat: A Key Inhibitor for Lysosomal Storage Disorders

Explore the critical role of Miglustat (N-Butyldeoxynojirimycin, CAS 72599-27-0) as a glucosylceramide synthase inhibitor. Learn about its applications in treating Gaucher and Niemann-Pick diseases and why sourcing from a reliable manufacturer is crucial.